Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1998-2-26
|
pubmed:abstractText |
Fungal vaginal infections/colonisations can be divided into a symptomatic vaginal candidiasis and an asymptomatic vaginal Candida-carriage. The latter seems to be a predisposing factor for the development of a symptomatic vaginal candidiasis. The fungal organism isolated most frequently is Candida albicans, followed by Candida glabrata, which was previously also known as Torulopsis glabrata. To a lower extend, other Candida species such as Candida tropicalis and Candida krusei can be prevalent in the vulvovaginal region. Predisposing factors for vaginal candidiasis are gravidity, diabetes mellitus or a therapy with immunosuppressive agents. Also gestagenes showed to be a pre-disposing factor for vaginal candidiasis. Divergent results concerning the predisposition to vaginal candidiasis or colonisation due to oral contraception have so far been reported. Therefore we performed a study with two healthy collectives of female volunteers (n = 2 x 60) which were different concerning the taking of oral contraceptives. Overall, in 17% of the subjects (20/120) yeast could be cultured out of the vaginal secretions. There was no evidence for a higher rate of Candida-colonisation in subjects taking oral contraceptives. Further, there was no evidence for a relationship between the length of the taking of oral contraceptives and the rate of vaginal yeast-carriage. Also the type of oral contraceptive (combination or sequential contraceptive) had no influence on the frequency of Candida-carriage. Candida albicans was the most prevalent yeast (16/20), followed by Candida glabrata (4/20).
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0044-4197
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
119
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
545-9
|
pubmed:dateRevised |
2008-2-11
|
pubmed:meshHeading |
pubmed-meshheading:9480609-Adult,
pubmed-meshheading:9480609-Candidiasis, Vulvovaginal,
pubmed-meshheading:9480609-Carrier State,
pubmed-meshheading:9480609-Contraceptives, Oral,
pubmed-meshheading:9480609-Dose-Response Relationship, Drug,
pubmed-meshheading:9480609-Female,
pubmed-meshheading:9480609-Humans,
pubmed-meshheading:9480609-Risk Factors,
pubmed-meshheading:9480609-Vagina
|
pubmed:year |
1997
|
pubmed:articleTitle |
[Oral contraceptive use and vaginal candida colonization].
|
pubmed:affiliation |
Institut für Mikrobiologie und Virologie, Universität Witten/Herdecke.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|